Agathe Richard is counsel in the Litigation Department of Willkie Farr & Gallagher LLP in New York. Agathe’s focus includes U.S. antitrust law and European competition law (merger control notifications with an emphasis on analysis and compliance under the Hart-Scott-Rodino Act, merger investigations, restrictive arrangements and monopolization cases).
Experience
- “A Holistic Assessment of Dynamic Competition”, Concurrences Review (2016) (co-authored)
- “In-House Practice For International Antitrust Investigation” (Lawline, 2014) (co-authored)
-
“Reverse Payment Settlements in the United States and Europe: Moving Toward An Effects-Based Approach”, CPI Antitrust Chronicle (September 2013) (co-authored)
Agathe advised on the following significant matters:
Merger Counseling
- Centerbridge/Davis Vision
- Interpublic Group/Acxiom Marketing Solutions
- W&W/AFCO Steel Corporation / Hirschfeld Industries
- BB&T/Swett & Crawford
- Constantia/Multi -Color Corporation
- Dormakaba/Stanley Black and Decker
- Tornier/ Wright Medical Group (approval following second request and consensual divestitures with FTC)
- Men’s Wearhouse/Jos. A. Bank (unconditional approval following second request by FTC)
- Teva Pharmaceuticals/Cephalon (Phase I with conditions, European Commission)
- Teva Pharmaceuticals/Ratiopharm (Phase I with conditions, European Commission)
- Gaz de France/Suez (Phase II with conditions, European Commission)
Investigations and Litigations
- Teva Pharmaceuticals in the Perindopril and Modafinil antitrust investigations by the European Commission
- High tech investigations in Europe, the United States, and Canada
Credentials
Education
Fordham University School of Law, LL.M., 2013 Université Paris II - Panthéon-Assas, DESS, 2005 HEC, Master, 2004 Université Paris I - Panthéon-Sorbonne, DESS, 2004